The use of HSP90 inhibitor AUY922 with platin-based radiation has shown efficacy in synergistic killing of mutant head and neck squamous cell carcinoma (HNSCC) cells through chromosomal fragmentation [119]. The gene discussed is HSP90AB1; the disease is head and neck squamous cell carcinoma.